Dear Editor, Epilepsy constitutes a group of chronic neurological disorders that can be diagnosed at all ages and is characterized by recurrent seizures in which abnormal electrical activity causes altered perception or behavior. The prevalence of epilepsy varies between countries and ethnic groups, and generally ranges from 0.1% to 0.5%, but this increases to more than 1% in underdeveloped countries. Multiple factors such as genetic and environmental factors are associated with the etiology of epilepsy. Epilepsy is genetically highly heterogeneous and shows a weak genotype-phenotype correlation.
More than two million people in Pakistan suffer from epilepsy, which constitutes around 5% of the epilepsy patients worldwide. However, genetic tests for epilepsy have rarely been performed in Pakistan. This study examined a large Pakistani autosomal dominant epilepsy family (family ID: EF-23) comprising seven siblings: five affected and two unaffected individuals (Fig. 1A) . The five affected family members had a history of complex partial seizures. All of them had experienced auditory auras or ictal aphasia followed by secondarily generalized tonic-clonic seizures (SGTCs), and one individual (II-1) additionally had visual symptoms followed by SGTCs. The ages at seizure onset ranged from 5 to 15 years (10.8±3.7 years, mean±SD). Both the seizure semiology and the neuropsychological findings pointed to lateral temporal lobe dysfunction in this ADLTE family. This study was approved by the IRB of Kongju National University (IRB No. KNU-IRB-2015-67-2) and Samsung Medical Center (IRB No. SMC 2015-08-057-002).
Exome sequencing of the proband (II-6) revealed a novel c.988C>T (p.R330X) nonsense mutation in LGI1. Sanger sequencing showed complete cosegregation of the mutation, with the five affected individuals in the EF-23 pedigree ( Fig. 1A and B) . The LGI1 mutation was located in the highly conserved third leucine-rich glioma-inactivated epitempin protein repeat domain ( Fig. 1C and D) . The p.R330X mutation was not reported in several global human genome databases, including the 1,000 Genomes Project (http://www.1000genomes.org/), Another nonsense mutation (p.R474X) in LGI1 has been reported in an ADLTE family. 3 In addition to the LGI1 p.R330X mutation, several rare or private nonsynonymous variants were identified in the epilepsy-related genes from the exome of the proband (Supplementary Table 1 in the online-only Data Supplement). However, they were not considered to be the underlying cause of the epilepsy phenotype due to the presence of nonsegregation within the family. Examination of mitochondrial DNA revealed no causative variants including long deletions or depletions.
This study has identified a novel LGI1 stop-gain mutation in a large autosomal dominant family with lateral temporal lobe epilepsy, which represents the first case of an LGI1 mutation in Pakistan. These findings will be helpful when setting up the molecular diagnosis of epilepsy in Pakistan.
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